tiprankstipranks
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
NMRA
Neumora Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see NMRA full AI Analyst Report?

Neumora Therapeutics, Inc. (NMRA) Income Statement

414 Followers

Neumora Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Neumora Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Neumora Therapeutics, Inc.'s net income was $-59.45M. See Neumora Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -5.00M$ 0.00$ -668.00K$ 0.00$ 0.00
Operating Expenses
$ 236.16M$ 263.46M$ 187.53M$ 135.87M$ 237.32M
Depreciation and Amortization
$ 208.00K$ 631.00K$ 668.00K$ 594.00K$ 538.00K
EBITDA
$ -233.37M$ -262.83M$ -187.53M$ -135.28M$ -236.78M
Operating Income
$ -241.16M$ -263.46M$ -188.19M$ -135.87M$ -237.32M
Other Income/Expenses
$ 4.36M$ 19.86M$ -47.46M$ 4.97M$ 11.00K
Pretax Income
$ -236.80M$ -243.61M$ -235.66M$ -130.90M$ -237.31M
Net Income
$ -236.93M$ -243.79M$ -235.93M$ -130.90M$ -237.31M
Per Share Metrics
Basic EPS
$ -1.45$ -1.53$ -1.49$ -0.86$ -1.56
Diluted EPS
$ -1.45$ -1.53$ -1.49$ -0.86$ -1.56
Weighted Average Shares Outstanding
 163.39M 159.38M 158.83M 151.95M 151.95M
Weighted Average Shares Outstanding (Diluted)
 163.39M 159.38M 158.83M 151.95M 151.95M
Currency in USD

Neumora Therapeutics, Inc. Earnings and Revenue History